These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17357142)

  • 1. Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
    Wilcox RA; Churchyard A; Dahl HH; Hutchison WM; Kirby DM; Thyagarajan D
    Mov Disord; 2007 May; 22(7):1020-3. PubMed ID: 17357142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions.
    Van Goethem G; Martin JJ; Van Broeckhoven C
    Acta Neurol Belg; 2002 Mar; 102(1):39-42. PubMed ID: 12094562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
    Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
    Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA; McDermott MP; Messing S
    Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease.
    Sharer JD
    IUBMB Life; 2005 Sep; 57(9):607-14. PubMed ID: 16203679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions.
    Moslemi AR; Melberg A; Holme E; Oldfors A
    Neurology; 1999 Jul; 53(1):79-84. PubMed ID: 10408540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions.
    Komaki H; Fukazawa T; Houzen H; Yoshida K; Nonaka I; Goto Y
    Ann Neurol; 2002 May; 51(5):645-8. PubMed ID: 12112115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism.
    Mancuso M; Filosto M; Oh SJ; DiMauro S
    Arch Neurol; 2004 Nov; 61(11):1777-9. PubMed ID: 15534189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal disorders of mitochondrial DNA maintenance.
    Van Goethem G
    Acta Neurol Belg; 2006 Jun; 106(2):66-72. PubMed ID: 16898256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset familial parkinsonism due to POLG mutations.
    Davidzon G; Greene P; Mancuso M; Klos KJ; Ahlskog JE; Hirano M; DiMauro S
    Ann Neurol; 2006 May; 59(5):859-62. PubMed ID: 16634032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa slows the progression of familial parkinsonism.
    Gwinn-Hardy K; Evidente VG; Waters C; Muenter MD; Hardy J
    Lancet; 1999 May; 353(9167):1850-1. PubMed ID: 10359414
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 19. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 20. [Motor fluctuations and dyskinesias in Parkinson's disease: variables that discriminate both complications in a sample of 285 patients].
    Gómez JC; Rouco I; Velasco F; Tijero B; Garamendi I; Lezcano E; Zarranz JJ
    Neurologia; 2008 Oct; 23(8):494-8. PubMed ID: 18770057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.